Blood Test for Early Detection of Cancer and Autoimmune Diseases
Nano Discovery Inc., FL, United States
We have developed a nanotechnology-enabled blood test for early detection and diagnosis of cancer and autoimmune diseases.
Primary Application Area: Medical Devices
Technology Development Status: Proven Manufacturability
Technology Readiness Level: TRL 7
FIGURES OF MERIT
Value Proposition: Non-invasive screening tests for early stage cancer detection and screening are almost non-existent for most cancer types. Many autoimmune conditions are not detected until they reached more debilitating advanced stages. Our test can potentially detect cancer and autoimmune conditions months even years before clinical diagnosis and symptoms to appear.
Organization Type: Early-stage Startup (Seed)
Showcase Booth #: 52M
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date: Florida Department of Health Bankhead-Coley Foundation, $100,000
Primary Sources of Funding: Angel, Friends, Family
Looking for: Development / License Partners